Get the Stockscreener App
66.44
0.48%
0.32
Overview
News
Price History
Option Chain
Financials
Why CCI Down?
Discussions
Forecast
Dividend History
Cigna Group stock is traded at $66.44, with a volume of 2.95M.
It is up +0.48% in the last 24 hours and down -11.86% over the past month.
Crown Castle owns or manages roughly 40,000 wireless towers in the United States. It leases space on its towers to wireless service providers, which install equipment to support their wireless networks. The company has a very concentrated customer base, with about 90% of its revenue from the Big Three US mobile carriers: Verizon, T-Mobile, and AT&T. Crown Castle has plans to divest its fiber business, which is expected to be finalized in the first half of 2026. After that, it will be a stand-alone tower operator. Crown Castle operates as a real estate investment trust.
See More
Previous Close:
$66.12
Open:
$66.29
24h Volume:
2.95M
Relative Volume:
0.84
Market Cap:
$28.27B
Revenue:
$4.21B
Net Income/Loss:
$-51.00M
P/E Ratio:
13.51
EPS:
4.9176
Net Cash Flow:
$2.73B
1W Performance:
-2.06%
1M Performance:
-11.86%
6M Performance:
-21.63%
1Y Performance:
-30.40%
1-Day Range:
$65.83
$68.17
1-Week Range:
$65.68
$68.17
52-Week Range:
$65.68
$100.50
Cigna Group Stock (CCI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(713) 570-3000
Address
8020 KATY FREEWAY, HOUSTON, TX
Compare CCI vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CCI
Cigna Group
|
66.44 | 28.86B | 4.21B | -51.00M | 2.73B | 4.9176 |
UNH
Unitedhealth Group Inc
|
371.90 | 327.80B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
86.46 | 110.58B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
386.43 | 85.90B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
270.53 | 71.88B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
388.36 | 47.78B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-26 | Initiated | Truist | Hold |
| Mar-23-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-05-26 | Initiated | Bernstein | Outperform |
| Jan-05-26 | Downgrade | New Street | Buy → Neutral |
| Dec-01-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-02-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-22-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-19-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Jul-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-19-25 | Resumed | BofA Securities | Buy |
| Mar-20-25 | Resumed | BofA Securities | Neutral |
| Mar-17-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Mar-17-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-14-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-14-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-14-25 | Upgrade | UBS | Neutral → Buy |
| Jan-27-25 | Initiated | JMP Securities | Mkt Outperform |
| Jan-13-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-02-25 | Downgrade | Jefferies | Buy → Hold |
| Dec-10-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-19-24 | Downgrade | Argus | Buy → Hold |
| Jan-19-24 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Dec-14-23 | Initiated | HSBC Securities | Hold |
| Dec-05-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-16-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-13-23 | Initiated | Scotiabank | Sector Perform |
| Aug-10-23 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-23 | Initiated | Argus | Buy |
| Jul-13-23 | Initiated | BMO Capital Markets | Underperform |
| Mar-30-23 | Upgrade | MoffettNathanson | Market Perform → Outperform |
| Jan-23-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-12-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jun-02-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-28-22 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-19-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-13-21 | Resumed | Wolfe Research | Underperform |
| Sep-10-21 | Downgrade | Oppenheimer | Outperform → Perform |
| May-04-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-12-21 | Resumed | Jefferies | Buy |
| Mar-26-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-19-21 | Initiated | Wolfe Research | Peer Perform |
| Mar-18-21 | Initiated | Wolfe Research | Outperform |
| Jan-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Dec-11-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-20-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-15-20 | Initiated | Barclays | Overweight |
| Jun-05-20 | Resumed | Deutsche Bank | Hold |
| May-22-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-28-20 | Initiated | Credit Suisse | Neutral |
| Aug-14-19 | Reiterated | BofA/Merrill | Buy |
| Aug-01-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-12-19 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-11-19 | Downgrade | UBS | Buy → Neutral |
| Mar-19-19 | Reiterated | BofA/Merrill | Buy |
| Mar-19-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-12-19 | Downgrade | Macquarie | Outperform → Neutral |
| Jan-14-19 | Downgrade | Goldman | Buy → Neutral |
| Jan-03-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-03-18 | Downgrade | MoffettNathanson | Buy → Neutral |
| Oct-16-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Jun-12-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-11-17 | Upgrade | Guggenheim | Neutral → Buy |
View All
Cigna Group Stock (CCI) Latest News
FBT Gibbons Beats DQ Bid In Suit Over Cigna Payments - Law360
Cigna Better Positioned to Meet Long-Term EPS Growth Targets, RBC Says - marketscreener.com
UBS reiterates Cigna stock buy rating on 2026-2030 outlook By Investing.com - Investing.com Canada
Cigna rated 'Strong Buy' with strong Q2 results and 10-14% EPS growth target through 2030. - Pluang
Cigna: Deeply Undervalued With Expected Double-Digit EPS Growth Ahead - Seeking Alpha
Jefferies Adjusts Price Target on Cigna Group to $288 From $307, Keeps Hold Rating - marketscreener.com
The Cigna Group (CI) Stock Forecasts - Yahoo Finance
The Cigna Group Unveils Lead to One and $3 Billion Plan at Investor Day - Grit Daily News
Crown Castle Announces Third Quarter 2026 Earnings Conference Call Details - GlobeNewswire Inc.
Cigna Group (CI), What Is Behind The Fresh Attention? - Yahoo Finance
After Investment Year in 2026, Cigna Aims to Reaccelerate Profit Growth - Morningstar
HCA Houston and Cigna locked in new contract dispute with deal set to expire - The Business Journals
Cigna Sets Long-Term Goals, Unveils 2030 Modernization Strategy - Benzinga
Cigna options flow turns bullish even as technicals signal sell - Investing.com
Cigna, Fla. Atty Resolve $21M Claim In Ch. 7 Case - Law360
What Cigna Group (CI)'s $3 Billion Modernization Plan Means For Shareholders - Simply Wall Street
Cigna Reaffirms 2026 Outlook, Targets Complex Care and AI-Driven Growth - Yahoo Finance
The Cigna Group (CI) Analyst/Investor DaySlideshow (NYSE:CI) 2026-09-30 - Seeking Alpha
Cigna Group expects $3B in savings driven by AI, automation - Modern Healthcare
Cigna Outlines $3 Billion Modernization, Productivity Initiative - 富途牛牛
The Cigna Group (CI) Reaffirms 2026 Outlook and Sets 10-14% Long-Term Adjusted EPS Growth Target at Investor Day - GuruFocus
Cigna launches $3B cost-savings initiative focused on AI, automation - Hartford Business Journal
Cigna Stock: Specialty Drug Growth Takes Focus at Investor Day - Barron's
Cigna Group (CI) Reaffirms FY26 Guidance Amid Investor Day Insig - GuruFocus
Cigna (CI) Unveils $3 Billion AI Initiative, Reaffirms 2026 Guid - GuruFocus
Cigna expects $3 billion in cost savings by 2030 - reuters.com
Cigna sets aside $3B to boost performance (CI:NYSE) - Seeking Alpha
Will New CEO’s Specialty Pharmacy Focus Reshape Cigna Group’s (CI) Evernorth and Signature Narrative? - Yahoo Finance
Cigna Group stock tracks new 2030 earnings targets - AD HOC NEWS
Cigna Group reaffirms 2026 outlook at investor day - StreetInsider
Cigna unveils $3B modernization plan and targets 10-14% EPS growth through 2030 with new personalization strategy - Pluang
The Cigna Group reaffirms 2026 guidance, unveils "Lead to One" and $3B modernization plan - TradingView
The Cigna Group Hosts 2026 Investor Day Introduces "Lead To One" To Drive Durable Growth Through Complex Care Leadership And Differentiated Capabilities - TradingView
Cigna To Ramp Up Investments In Specialty Pharmacy And Complex Care - currently.att.yahoo.com
Cigna unveils $3B productivity initiative, including use of AI - Healthcare Dive
Have Cigna insurance? Your St. David’s care could cost more starting Thursday - Austin American-Statesman
Cigna, OpenAI partner on AI-driven personalized cancer care - TechTarget
Cigna Group stock trades flat as Investor Day nears - AD HOC NEWS
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
Cigna and OpenAI collaborate on complex condition support - Healthcare Finance News
Cigna Group and OpenAI Partner to Support Patients With Complex Conditions - Digital Health News
The Cigna Group stock falls 1.03 percent after Q2 beat - AD HOC NEWS
Cigna Group (CI) Looks 58% Undervalued, Is The Recent Pullback A Buying Opportunity? - simplywall.st
Cigna Group stock slips 4.3 percent ahead of the open - AD HOC NEWS
Cigna Group, OpenAI team up to support patients with complex conditions - Fierce Healthcare
Cigna Group stock underperforms Thursday when compared to competitors - MarketWatch
UHC, Cigna and Centene Sign On to New National Shared Credentialing Program - MedCity News
Cigna Group, OpenAI partner to expand complex condition care - Modern Healthcare
The Cigna Group (CI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cigna Group stock slips 0.32 percent ahead of the open - AD HOC NEWS
Cigna Group stock underperforms Wednesday when compared to competitors - MarketWatch
Cigna Group Stock (CCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):